Highlights From the American Heart Association's Scientific Sessions-ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, and Aspirin and Dementia.
JAMA
; 327(4): 310-312, 2022 Jan 25.
Article
in English
| MEDLINE | ID: covidwho-2127391
Subject(s)
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Aspirin
/
Dementia
/
Apolipoprotein B-100
/
PCSK9 Inhibitors
/
Hypercholesterolemia
Type of study:
Prognostic study
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
JAMA
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS